Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/22/2934201/0/en/Kane-Biotech-Announces-Distribution-Agreement-with-Razan-Medical-Trading-for-revyve-Antimicrobial-Wound-Gel.html
https://www.globenewswire.com/news-release/2024/08/22/2934610/0/en/Kane-Biotech-to-Release-Second-Quarter-2024-Financial-Results-on-August-29-2024-Conference-Call-to-Follow.html
https://www.globenewswire.com/news-release/2024/07/23/2917220/0/en/Kane-Biotech-Receives-FDA-Approval-to-Increase-Dosage-Allowance-of-its-revyve-Antimicrobial-Wound-Gel.html
https://www.globenewswire.com/news-release/2024/07/17/2914550/0/en/Kane-Biotech-Receives-ISO-13485-2016-MDSAP-Quality-Certification.html
https://www.globenewswire.com/news-release/2024/07/15/2913043/0/en/Kane-Biotech-Announces-Issuance-of-Restricted-Share-Units.html
https://www.globenewswire.com/news-release/2024/07/11/2911817/0/en/Kane-Biotech-Signs-Worldwide-License-Agreement-with-Omni-Bioceutical-Innovations-Inc.html
https://www.globenewswire.com/news-release/2024/06/27/2905191/0/en/Kane-Biotech-Makes-First-Commercial-Sale-of-revyve-Antimicrobial-Wound-Gel-to-ProgenaCare-Global.html
https://www.globenewswire.com/news-release/2024/06/25/2903768/0/en/Kane-Biotech-Signs-Worldwide-License-Agreement-with-Montreal-Based-I-MED-Pharma-Inc.html
https://www.globenewswire.com/news-release/2024/05/23/2887654/0/en/Kane-Biotech-Announces-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/16/2883341/0/en/Kane-Biotech-to-Release-First-Quarter-2024-Financial-Results-on-May-23-2024.html